Publications by authors named "Sabine Junge"

Claim this Profile
P
Paclitaxel/Ramucirumab versus Paclitaxel in 2nd-Line Therapy of Advanced Esophageal Squamous Cell Carcinoma: Randomized Phase II IKF-AIO-RAMOS Trial.
Magdalena K Scheck, Thorsten O Goetze, Thomas J Ettrich, Harald Schmalenberg, Michael Clemens, Sabine Junge

Oncol Res Treat· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of ramucirumab combination chemotherapy as second-line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first-line therapy.
Michael Masetti, Salah-Eddin Al-Batran, Thorsten O Goetze, Peter Thuss-Patience, Jorge Riera Knorrenschild, Sabine Junge

Int J Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis